Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.380
-0.010 (-0.72%)
At close: Mar 6, 2026, 4:00 PM EST
1.398
+0.018 (1.33%)
After-hours: Mar 6, 2026, 5:31 PM EST
Marker Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 4.69 | 6.59 | 3.31 | 3.51 | 1.24 | 0.47 | Upgrade
|
| Revenue Growth (YoY) | -12.99% | 99.06% | -5.76% | 182.96% | 166.01% | 118.95% | Upgrade
|
| Cost of Revenue | 13.76 | 13.47 | 10.42 | 11.97 | 27.79 | 18.88 | Upgrade
|
| Gross Profit | -9.07 | -6.88 | -7.11 | -8.45 | -26.55 | -18.41 | Upgrade
|
| Selling, General & Admin | 4.37 | 4.24 | 7.48 | 11.34 | 12.92 | 10.47 | Upgrade
|
| Research & Development | 0.98 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 5.35 | 4.24 | 7.48 | 11.34 | 12.92 | 10.47 | Upgrade
|
| Operating Income | -14.41 | -11.12 | -14.58 | -19.79 | -39.48 | -28.89 | Upgrade
|
| Interest & Investment Income | 0.5 | 0.44 | 0.54 | 0.25 | 0.01 | 0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.12 | - | - | - | - | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -13.79 | -10.68 | -14.04 | -19.54 | -39.47 | -28.71 | Upgrade
|
| Other Unusual Items | -0.45 | - | - | -0.23 | -2.41 | - | Upgrade
|
| Pretax Income | -14.25 | -10.68 | -14.04 | -19.78 | -41.88 | -28.71 | Upgrade
|
| Income Tax Expense | 0.05 | 0.05 | 0 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -14.3 | -10.73 | -14.05 | -19.78 | -41.88 | -28.71 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 5.81 | -10.15 | - | - | Upgrade
|
| Net Income | -14.3 | -10.73 | -8.24 | -29.93 | -41.88 | -28.71 | Upgrade
|
| Net Income to Common | -14.3 | -10.73 | -8.24 | -29.93 | -41.88 | -28.71 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 9 | 9 | 8 | 8 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 9 | 9 | 8 | 8 | 5 | Upgrade
|
| Shares Change (YoY) | 43.29% | 1.94% | 5.49% | 9.16% | 62.64% | 3.19% | Upgrade
|
| EPS (Basic) | -1.12 | -1.19 | -0.94 | -3.58 | -5.47 | -6.10 | Upgrade
|
| EPS (Diluted) | -1.12 | -1.19 | -0.94 | -3.59 | -5.47 | -6.10 | Upgrade
|
| Free Cash Flow | -14.82 | -10.91 | -16.44 | -26.97 | -30.41 | -29.29 | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -1.22 | -1.87 | -3.23 | -3.98 | -6.23 | Upgrade
|
| Gross Margin | -193.12% | -104.33% | -214.60% | -240.64% | - | - | Upgrade
|
| Operating Margin | -307.02% | -168.69% | -440.37% | -563.28% | -3179.32% | -6188.25% | Upgrade
|
| Profit Margin | -304.54% | -162.82% | -248.76% | -851.87% | -3372.68% | -6149.74% | Upgrade
|
| Free Cash Flow Margin | -315.59% | -165.53% | -496.51% | -767.66% | -2449.11% | -6274.32% | Upgrade
|
| EBITDA | - | - | -11.79 | -17 | -37.33 | -28.4 | Upgrade
|
| D&A For EBITDA | - | - | 2.79 | 2.79 | 2.15 | 0.49 | Upgrade
|
| EBIT | -14.41 | -11.12 | -14.58 | -19.79 | -39.48 | -28.89 | Upgrade
|
| EBIT Margin | - | -168.69% | - | - | - | - | Upgrade
|
| Revenue as Reported | 4.69 | 6.59 | 3.31 | 3.51 | 1.24 | 0.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.